Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment

Anti-PD-1 therapy has revolutionized the clinical treatment of lung cancer. With the increasing number of lung cancer patients being treated, there is also an increase in the number of immune-related adverse events (irAEs) being reported. These irAEs involve multiple organs and systems, mainly manif...

Full description

Bibliographic Details
Main Authors: Xiaohu Zheng, Haiming Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.628243/full